| Pharmaceutical Information |
| Drug Name |
Trimethadione |
| Drug ID |
BADD_D02287 |
| Description |
An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378) |
| Indications and Usage |
Used in the control of absence (petit mal) seizures that are refractory to treatment with other medications. |
| Marketing Status |
approved |
| ATC Code |
N03AC02 |
| DrugBank ID |
DB00347
|
| KEGG ID |
D00392
|
| MeSH ID |
D014293
|
| PubChem ID |
5576
|
| TTD Drug ID |
D0U4VT
|
| NDC Product Code |
Not Available |
| UNII |
R7GV3H6FQ4
|
| Synonyms |
Trimethadione | Troxidone | Tridione | Trimetin |
|
| Chemical Information |
| Molecular Formula |
C6H9NO3 |
| CAS Registry Number |
127-48-0 |
| SMILES |
CC1(C(=O)N(C(=O)O1)C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
